BioVaxys Technology's market cap is currently $7.29M. The company's EPS TTM is C$-0.031; its P/E ratio is ―; BioVaxys Technology is scheduled to report earnings on October 2, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
